Skip to main content

Table 2 Cycle outcomes of ATA-negative and ATA-positive patients

From: The impact of thyroid autoantibodies on the cycle outcome and embryo quality in women undergoing intracytoplasmic sperm injection

Variable ATA negative (n = 250) ATA positive (n = 65) p
Total dose of gonadotropins (IU) 1910.0 ± 749.7 2073.1 ± 754.6 0.09
Peak estradiol (pg/mL) 2069.1 ± 1214.0 2185 ± 1273.1 0.45
Serum progesterone (ng/mL) 0.75 ± 0.52 0.69 ± 0.36 0.74
No. of retrieved oocytes 8.3 ± 3.9 8.5 ± 4.6 0.87
No. of metaphase 2 oocytes 5.3 ± 3.2 5.6 ± 3.5 0.66
Fertilization rate (%) 97.1 ± 10.5 91.5 ± 19.8 0.003
Cleavage rate (%) 99.9 ± 0.9 97.7 ± 13.8 0.05
Presence of top-quality embryo (%) 67.8 56.5 0.09
Implantation rate (%) 50.4 50.8 0.95
Miscarriage rate (%) 9.6 12.7 0.47
  1. ATA anti-thyroid antibody
  2. Values are mean ± SD or (%)